Title:
AMINO HETEROARYL COMPOUNDS AND COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2022/193499
Kind Code:
A1
Abstract:
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to Tyrosine kinase 2 (TYK2). The compounds herein are typically TYK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as an autoimmune disorder or an inflammatory disorder, e.g., psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, and/or systemic lupus erythematosus.
More Like This:
Inventors:
CHENG DAI (CN)
DING QIANG (CN)
DING QIANG (CN)
Application Number:
PCT/CN2021/106028
Publication Date:
September 22, 2022
Filing Date:
July 13, 2021
Export Citation:
Assignee:
ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD (CN)
International Classes:
C07D401/10; A61K31/501; A61P17/06; A61P29/00; A61P37/00; C07D401/12; C07D403/10; C07D403/12; C07D413/10; C07D413/12
Domestic Patent References:
WO2020086616A1 | 2020-04-30 | |||
WO2014074661A1 | 2014-05-15 | |||
WO2020092196A1 | 2020-05-07 | |||
WO2015069310A1 | 2015-05-14 | |||
WO2020159904A1 | 2020-08-06 |
Foreign References:
CN111484480A | 2020-08-04 | |||
CN111909140A | 2020-11-10 |
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS, P.C. (CN)
Download PDF: